Bibliographic Info
GuidelineConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year of Publication2021
Issuing InstitutionWHO
Recommendation
Status
Updated
Recommended in favor
Strong
Certainty of evidence
Low
dolutegravir (DTG) is recommended as the preferred third drug for HIV post-exposure prophylaxis for children for whom an approved DTG dosing is available